Key result
Different positional isomers of a synthetic non-nucleoside triphosphate dramatically altered myosin's force and motion generating capacity, with ortho-AzoTP yielding ~65% of the actin filament velocity of ATP.
Why the study?
Dysfunction of molecular motors causes many pathologies, necessitating intrinsic control over molecular motor function through alternative energy sources.
Subtle variations in the structure of an abiotic energy source (positional isomers) can be used to control the force and motility of myosin without altering its structure.
No clinical implications yet; leaves open isomer-based modulation of cardiac myosin in vivo.
Molecular motors have evolved to transduce chemical energy from adenosine triphosphate into mechanical work to drive essential cellular processes, from muscle contraction to vesicular transport. Dysfunction of these motors is a root cause of many pathologies necessitating the need for intrinsic control over molecular motor function. Herein, we demonstrate that positional isomerism can be used as a simple and powerful tool to control the molecular motor of muscle, myosin. Using three isomers of a synthetic non-nucleoside triphosphate we demonstrate that myosin’s force and motion generating capacity can be dramatically altered at both the ensemble and single molecule levels. By correlating our experimental results with computation, we show that each isomer exerts intrinsic control by affecting distinct steps in myosin’s mechano-chemical cycle. Our studies demonstrate that subtle variations in the structure of an abiotic energy source can be used to control the force and motility of myosin without altering myosin’s structure. Statement of Significance Molecular motors transduce chemical energy from ATP into the mechanical work inside a cell, powering everything from muscle contraction to vesicular transport. While ATP is the preferred source of energy, there is growing interest in developing alternative sources of energy to gain control over molecular motors. We synthesized a series of synthetic compounds to serve as alternative energy sources for muscle myosin. Myosin was able to use this energy source to generate force and velocity. And by using different isomers of this compound we were able to modulate, and even inhibit, the activity of myosin. This suggests that changing the isomer of the substrate could provide a simple, yet powerful, approach to gain control over molecular motor function.
No takes yet. Share an insight, caveat, or question.
Woodward et al. (2019) studied this question. Positional isomers of azobenzene-based non-nucleoside triphosphate (AzoTP) vs. ATP was evaluated on Actin filament velocity (Vactin). Different positional isomers of a synthetic non-nucleoside triphosphate dramatically altered myosin's force and motion generating capacity, with ortho-AzoTP yielding ~65% of the actin filament velocity of ATP.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: